Aluminum-induced neurotoxicity and oxidative damage in rabbits: Protective effect of melatonin

Neuroendocrinology Letters

Volumn 26, Issue 5, 2005, Pages 609-616

  Abd Elghaffar, Sary Kh ^a   El Sokkary, Gamal H ^a   Sharkawy, Ahmed A ^b  

^a Assiut University   (Egypt)

^b Faculty of Veterinary Medicine   (Egypt)

Author keywords

Aluminum neuropathy; Histomathology; Melatonin; Oxidative stress

Indexed keywords

ALUMINUM CHLORIDE; MALONALDEHYDE; MELATONIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATROPHY; BRAIN CORTEX; BRAIN DISEASE; CELL DEGENERATION; CONTROLLED STUDY; DEMYELINATION; ELECTRON MICROSCOPY; ENZYME INHIBITION; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MORPHOLOGY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RABBIT; SCHWANN CELL; SPECTROPHOTOMETRY;

EID: 29544449396     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Nicolini M, Zatta PF and Corain B. Aluminum in Chemistry, Biology and Medicine, Cortina Intern, Verona and Raven Press, New York. 1992
2. Meranger JC. How aluminum levels in subsurface drinking water supplies in Canada can be used to predict possible impact by acidic deposition. In: Environmental Chemistry and Toxicology of Aluminum. Lewis, T.E.(ed), Lewis Publications, Chelsea, MI, 1989; pp. 107-116.
3. Rifat SL, Eastwood MR, Crapper McLachlan DR and Corry PN. Effects of exposure of miners to aluminum powder. Lancet 1990; 336:1162-1165.
4. Kristensen C, Ingmundson P, Vogel H, Robbins C and Borcherding S. Aluminum intoxication and neuropsychologic dysfunction in chronic dialysis patients. Kidney Int. 1990; 37:305.
5. McLachlan DRC, Kruck TP, Lukiw WJ and Krishnan SS. Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease? Canadian Medical Association Journal 1991; 145:793-804.
6. Epstein SG. Aluminum and health: an update on Alzheimer's Disease. Washington, DC: Aluminum Association 1987.
7. Graves AB, White E, Koepsell TD, Reifler BV, Van Belle, and Larson EB. The association between aluminum-containing products and Alzheimer's disease. J Clin Epidemiol 1990; 43:35-44.
8. Walton L. Alzheimer's disease and the environment (editorial). Journal of the Royal Society of Medicine 1992; 85:69-70.
9. Greger JL. Aluminum content of the American diet. Fd. Technol 1985; 39:73.
10. Michel P, Commenges D, Dartigues JF. Study of the relationship between Alzheimer's disease and aluminum in drinking water. Neurobiol Aging 1990; 11:264.
11. Kawachi and Pearce N. Aluminum in the drinking water is it safe? Australian Journal of public Health 1991; 15:84-87.
12. Aikoh H and Nishio M. Aluminum content of various canned and bottled beverages. Bull. Environ. Contam.Toxicol 1996; 56:1-7.
13. Brown S, Mendoza N, Bertholt RK, Ross R, Wills MR, Savory J and Krantz KD. Absorption of aluminum from aceglutamide in healthy adult males. Res. Commun. Chem. Pathol. Pharmacol 1986; 53:105-116.
14. Nathan E and Pedersen SE, Dialysis encephalopathy in a nondialyzed uraemic boy treated with aluminum hydroxide orally. Acta paediatr. Scand 1980; 69:793-796.
15. Cannata JB, Briggs JD, Junor BJ and Fell GS. Effects of acute aluminum overload on calcium and parathyroid hormone metabolism. Lancet 1983; I: 501 -503.
16. Lione A. Aluminum toxicology and the aluminum-containing medications. Pharmacol. Ther, 1985; 29: 255-285.
17. Marquis JK. Neurotoxicity of aluminum. In: Environmental chemistry and toxicology of aluminum. Lewis, T.L. (ed). Michigan: Publ. Chelsea. 1989; 289-298.
18. Sturman JA and Wisniewski HM. Aluminum. In: Metal neurotoxicity. Bondy, S. C., Prased, K. N. (eds), Boca Raton: CRC Press. 1988; 62-80.
19. Bolla KJ, Briefel G, Spector D, Schwarz BS, Wieler BS, Herron J and Gimenez L. Neurocognitive effects of aluminum. Arch. Neurol 1992; 49:1021-1026.
20. Comissaris RL, Cordon JJ, Sprague S, Keiser J, Mayor GH. and Rech RH. Behavioral changes in rats after chronic aluminum and parathyroid administration. Neurobehav. Toxicol Teratol. 1982; 4:403-410.
21. Connor DJ, Jope RS and Harrel LE. Chronic aluminum administration to rats: Cognition and cholinergic parameters. Pharmacol Biochem Behav 1988; 31:467-474.
22. Gonda Z, Miklosi A and Kornelia L. The effect of social learning on a conditioned Avoidance response of rats treated prenatally with aluminum lactate. Neurotoxicology and Teratology 1997; 19: 59-63.
23. De Boni UD, Otvos A, Scott JW and Crapper DR. Neurofibrillary degeneration induced by systemic aluminum. Acta Neuropathol. (Berl.) 1976; 35:285-294.
24. Uemura, E. and Ireland, W. P. Synaptic density in chronic animals with experimental neurofibrillary changes. Exp. Neuro 1984; 85:1-9.
25. Reusche E, Koch V, Lindner B, Harrison AP, Fridrich H J. Alzheimer morphology is not increased in dialysis-associated encephalopathy and long-term hemodialysis. Acta Neuropathol (Berl) 2001; 101:211-216.
26. Shirabe T, Irie T and Uchida M. Autopsy case of aluminum encephalopathy. Neuropathology, 2002; 22:206-210.
27. Suarez-Fernandez MB, Soldado A B, Sanz-Medel A, Vega JA, Novelli A and Fernandez Sanchez MT. Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death. Brain Res 1999; 835:125-36.
28. Bubenik GA, Blask DE, Brown GM, Maestroni GL, Pang SF, Reiter RJ, Viswanathan M and Zisapel N. Prospects of the clinical utilization of melatonin. Biol. Signals Recept 1998; 7:195-219.
29. Van Rensburg SJ, Daniels WM, Potocnik FC, Van Zyl JM, Taljaard JJ and Emsley R. A new model for the pathophysiology of Alzheimer's disease. Aluminum toxicity is exacerbated by hydrogen peroxide and attenuated by an amyloidal protein fragment and melatonin. S After Med J 1997; 87: 1111-1115.
30. Coles EH. Veterinary Clinical Pathology. 4 th Ed. W.B. Saunders Company, Philadelphia and London. 1986.
31. Esterbauer H and Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods in Enzymology; 1990; 186:407-421.
32. Bradford M. Rapid and sensitive method for quantification of protein utilizing the principle of protein-day binding. Analytical Biochemistry; 1976; 72:248-254.
33. Misra HP and Fridovich I. The role of superoxide anion in the autoxidation of Epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem., 1972; 247:3170-3175.
34. Bancroft, J. D and Stevens, A. Theory and Practice of Histologic Technique. 2 nd Ed., Churchill Livingstone. 1982; pp. 482-518.
35. Jayman, T. C. Z. and Sivasubramaniam, S. The use of ascorbic acid to eliminate interference from iron in the aluminon. Method for determining aluminum. Analyst (London) 1974; 99:296-301.
36. El-Sokkary, G. H. Melatonin protects against oxidative stress induced by the kidney carcinogen KBrO3. Neuroendocrinology Lett 2000; 21:461-468.
37. Julka D an Gill KD. Effect of aluminum on regional brain antioxidant defense status in Wister rats. Res Exp Med (Ber1) 1996; 196:187-94.
38. Jia Y, Zhong C, Wang Y and Zhao R. Effects of aluminum intake on the content of aluminum, iron, zinc and lipid peroxidation in the hippocampus of rats. Wei Sheng Yan Jia 2001; 30:132-134.
39. Amador FC, Santos MS and Oliveira CR. Lipid peroxidation facilitates aluminum accumulation in rat brain synaptosomes. J Toxicol Environ Health 1999; 58:427-435.
40. Ward RJ, Zhang Y and Crichton RR. Aluminum toxicity and iron homeostasis. J Inorg Biochem 2001; 87:9-14.
41. Erasmus, R. T.; Savory, J.; Wills, M. R. and Herman, M. M. Aluminum neurotoxicity in experimental animals. There Drug Monet 1993; 15:588-92.
42. He BP and Strong MJ. Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative Study of ALS and chronic aluminum chloride neurotoxicity in New Zealand white rabbits. Neuropathol Appl Neurobiol 2000; 26:150-60.
43. Yokel RA. The toxicology of aluminum in the brain: a review. Neurotoxicology 2000; 21:813-28.
44. El-Rahman SS. Neuropathology of aluminum toxicity in rats (glutamate and GABA impairment). Pharmacol Res 2003; 47:189-94.
45. Otaiza PI, Fraga CG and Keen CL. Aluminum has both oxidant and antioxidant effects in mouse brain membranes. Arch Biochem Biophys 1993; 300:516-521.
46. Savory J, Herman NM and Chribi O. Intracellular mechanisms underlying aluminium-induced apoptosis in rabbit brain. J. Inorg. Biochem. 2003; 97:151-154.
47. El-Sokkary GH, Reiter RJ and Abdel-Ghaffar SKh. Melatonin suoplementation restores cellular proliferation and DNA synthesis in the splenic and thymic lymphocytes of old rats. Neuroendocrinology Lett 2003; 24:215-223.
48. Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56:359-384.
49. Acuña-Castroviejo D, Coto-Montes A, Monti MG, Ortiz GG and Reiter RJ. Melatonin is protective against MPTP-induced striatal an hippocampal lesiona. Life Sci 1997; 60:PL23-PL29
50. Jin BK, Shin DY, Jeoing MY, Gwag MR, Baik HW, Yoon SK, Cho YH, Joo WS, Kim YS and Baik HH. Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rets. Neurosci Lett 1998; 245:61-64.
51. Giusti P, Lipartiti M, Franceschini D, Schiavo N and Floreani M. Neuroprotection by melatonin from kainatc-induced excitotoxicity in rats. FASEB J 1996; 10:891-896.
52. Tan DX, Manchester LC, Reiter RJ, Qi W, Kim SJ and El-Sokkary GH. Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice. J neurosci Res 1998; 54:282-289.
53. Lezoualc'h F, Skutella T, Widmann M and Behl C. Melatonin prevents oxidative stress-induced cell death in hippocampal cells. NeuroReport 1996; 7:2071-2077.
54. Skaper SD, Ancona B, Facci L, Franceschini D and Giusti P. Melatonin prevents the delayed death of hippocampal neurons induced by enhanced excitatory neurotranmission and the nitridergic pathway. FASEB J 1998; 12:725-731.
55. El-sokkary GH, Kamel ES and Reiter RJ. Prophylactic effect of melatonin in reducing lead-induced neurotoxicity in the rat. Cellular & Molec Biol Lett 2003; 8:461-470.
56. Pappolla MA, Sos M, Omar RA, Bick RJ, Hickson-Bick DLM, Reiter RJ. Efthimiopoulos, S. and Robakis, N. K. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci 1997; 17:1683-1690.
57. Lapin IP, Mirzaev SM, Ryzov IV and Oxenkrug GF. Anticonvulsant activity of melatonin against scizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice. J Pineal Res 1998; 24:215-218.
58. Southgate GS, Daya S and Potgieter B. Melatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus. J Chem Neuroanal 1998; 14:151-156.
59. Manev H, Uz T, Kharlamov A and Joo J-Y. Increased brain damage after stroke or excitotoxic scizures in melatonin-deficient rats. FASEB J 1996; 10:1546-1551.
60. Benitez-King G and Anton-Tay F. Calmodulin mediates melatonin cytoskeletal effects. Experientia 1993; 49:635-641.
61. Huerto-Delgadillo L, Anton-Tay F and Benitez-King G. Effects of melatonin in microtubule assembly dependent on hormone concentration: role of melatonin as a calmodulin antagonist. J. Pineal Res 1994; 17:55-62.
62. Floreani M, Skaper SD, Facci L, Lipartiti M and Giusti P. Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues. FASEB J 1997; 11:1309-1315.
63. Mohan N, Sadeghi K, Reiter RJ and Meltz ML. The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-B. Biochem Mol Biol Int 1995; 37:1063-1070.
64. Gilad E, Wong HR, Zingarelli B, Virág L, O'Connor M, Salzman AL and Szabó C. Melatonin inhibits expression of the iducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NF-B activation. FASEB J 1998; 12:685-693.
65. Cazevieille C, Safa R and Osborne NN. Melatonin protects primary neuronal cultures of rat cortical neurons from NMDA excitotoxicity and hypoxia/reoxygenation. Brain Res 1997; 768:120-124.
66. Kondoh T, Uneyama H, Nishino H and Torii K. Melatonin reduces cerebral edema formation caused by transient forebrain ischemia in rats. Life Sci 2002; Dec 72:583-90.